|
|
Volumn 4, Issue 9, 2003, Pages 813-
|
|
Destination: Tumor eradication
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD20 ANTIGEN;
FC RECEPTOR;
IMMUNOGLOBULIN G;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
MONOCLONAL ANTIBODY;
RITUXIMAB;
TRASTUZUMAB;
TUMOR ANTIGEN;
TUMOR VACCINE;
ANTIGEN EXPRESSION;
ANTINEOPLASTIC ACTIVITY;
AUTOIMMUNITY;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
DRUG DESIGN;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
MUTATION;
PRIORITY JOURNAL;
TUMOR IMMUNITY;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
|
|
EID: 0041381377
PISSN: 15292908
EISSN: None
Source Type: Journal
DOI: 10.1038/ni0903-813 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|